Davide Capodanno
University of Catania
Internal medicineRadiologySurgeryCardiologyRandomized controlled trialIntensive care medicineAntithromboticAspirinAcute coronary syndromeClopidogrelCoronary artery diseaseStentPercutaneous coronary interventionPercutaneousPopulationIn patientConventional PCIMyocardial infarctionStrokeMedicine
626Publications
76H-index
16.8kCitations
Publications 633
Newest
Source
#1Ovidio De Filippo (UNITO: University of Turin)H-Index: 8
#2Fabrizio D'AscenzoH-Index: 58
Last. Daniela TrabattoniH-Index: 30
view all 37 authors...
OBJECTIVES: This study assesses the safety and efficacy of thin-strut stents in non-left main (non-LM) bifurcation coronary lesions. BACKGROUND: Thinner struts of recent drug-eluting stent (DES) devices are associated with improved outcomes, but data about their performance in challenging scenarios are scant. METHODS: RAIN was a retrospective multicenter registry enrolling patients with coronary bifurcation lesions or left main (LM) disease treated with thin-strut DESs. Target-lesion revasculari...
Source
Source
#1Paolo Calabrò (Seconda Università degli Studi di Napoli)H-Index: 53
#2Felice Gragnano (Seconda Università degli Studi di Napoli)H-Index: 18
Last. Elisabetta Moscarella (Seconda Università degli Studi di Napoli)H-Index: 13
view all 21 authors...
Contemporary evidence supports device-based transcatheter interventions for the management of patients with structural heart disease. These procedures, which include aortic valve implantation, mitr...
Source
Source
Source
#1Dario CalderoneH-Index: 2
#2Antonio Greco (University of Catania)H-Index: 6
Last. Davide Capodanno (University of Catania)H-Index: 76
view all 8 authors...
Aims - The efficacy and safety of aspirin for primary cardiovascular disease (CVD) prevention is controversial. The aim of this study was to investigate the merits of aspirin in subjects with no overt CVD, with a focus on age as a treatment modifier. Methods and results - Randomized trials comparing aspirin use versus no aspirin use or placebo were included. The primary efficacy outcome was all-cause death. The primary safety outcome was major bleeding. Subgroups analyses were conducted to inves...
Source
#1Giovanni Occhipinti (University of Catania)H-Index: 2
#2Davide Capodanno (University of Catania)H-Index: 76
Dual antiplatelet therapy (DAPT) is mandatory in patients undergoing percutaneous coronary interventions (PCIs), but carries an increased bleeding risk which must be weighed over the expected antithrombotic benefit. In recent years, DAPT optimization strategy has been enriched by the concept of early withdrawal of aspirin ('aspirin-free' strategy). This strategy is supported by the modern advancements in pharmacological and procedural fields (i.e. the availability of P2Y12 receptor inhibitors wi...
Source
Objectives: To investigate how the changes of left ventricle ejection fraction (LVEF) between admission and discharge affected the long-term outcome in patients who underwent percutaneous edge-to-edge mitral valve repair for secondary mitral regurgitation. Background: An acute impairment of LVEF after surgical repair of mitral regurgitation, known as afterload mismatch, has been associated with increased all-cause mortality. Afterload mismatch after percutaneous edge-to-edge mitral valve repair ...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.